Why Drugmakers’ Abortion Pill Battle is Such a Big Deal
Posted inBank of America Corporation Buffett, Warren E Credit Suisse Group AG Decisions and Verdicts Doerr, John Federal Reserve Bank of New York Federal Reserve System Food and Drug Administration Gershkovich, Evan Home Box Office internal-storyline-no Kacsmaryk, Matthew Moritz, Michael Jonathan Musk, Elon Newsom, Gavin Ocasio-Cortez, Alexandria Regulation and Deregulation of Industry Silicon Valley Bank Supreme Court (US) Tesla Motors Inc Twitter UBS AG Warner Bros Discovery Warner Media LLC Warren, Elizabeth Winklevoss, Cameron;Winklevoss, Tyler

Why Drugmakers’ Abortion Pill Battle is Such a Big Deal

The decision by a Texas judge to overturn F.D.A. approval for the abortion pill mifepristone could upend the pharmaceutical industry.
UBS and Other Bank Stocks Fall After Credit Suisse’s Firesale
Posted inBank of England Banking and Financial Institutions Barr, Michael Barr, Michael S Bear Stearns Cos Biden, Joseph R Jr Buffett, Warren E Credit Suisse Group AG Federal Reserve System Goldman Sachs Group Inc Holmes, Elizabeth (1984- ) House Financial Services Committee internal-storyline-no JPMorgan Chase & Company Kelleher, Colm Lankford, James Lehman Brothers Holdings Inc Morgan Stanley Quattrone, Frank P Signature Bank Silicon Valley Bank Standard & Poor's Corp UBS AG Warren, Elizabeth Washington Mutual Inc

UBS and Other Bank Stocks Fall After Credit Suisse’s Firesale

Investors are still spooked after UBS bought its Swiss peer, with confidence in the banking sector in short supply.
Demystifying the Trillion Dollar Debate Over Share Buybacks
Posted inBank of America Corporation Benioff, Marc Berkshire Hathaway Inc Biden, Joseph R Jr Bridgewater Associates Buffett, Warren E CFA Institute Dalio, Raymond (1949- ) Federal Reserve System Instagram Inc internal-storyline-no National Economic Council (US) Rock, Chris Salesforce.com Inc Stock Buybacks Stocks and Bonds TikTok (ByteDance)

Demystifying the Trillion Dollar Debate Over Share Buybacks

The White House is at odds with business leaders over share repurchase programs. DealBook digs into the numbers to see who’s gaining from the practice.